Acurx Pharmaceuticals entered into a Securities Purchase Agreement with an investor for a registered direct offering, issuing shares of common stock and pre-funded warrants for gross proceeds of $4.0 million.
AI Assistant
ACURX PHARMACEUTICALS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.